5Corona Gutiems CM, Tinoco A, Navarro T, et al. Therapeutic vaccination with MVAF2 carl eliminate precarrcerous lesions associated with infection by oacogenic human papillounavious [J]. Human,Gene Ther, 2004; 15: 421-431
6Benedet JL, Miller DM, Nickerson KG. Results of conservative management of cervical intraepithelial neoplasia [J]. Obstst Gynecol, 1992 ; 79 ; 105-110
7Nuovo J, Melnikow J, Will- AR, et al. Treatment outcomes for squmnous intraepithelial lesions[J]. Int J Gynaecol Obstet, 2000 ; 68 : 25-33
8Higgins RV, van Nagell JR Jr, Donaldson Es, et al. The efficacy of laser therapy in the treatment of cervical intraepithelial neoplmia[J]. Gynecol 0ncol,1990;36;79-81
10Reich O, Pickel H, Lahournr M, et al. Cervical intraepithelialneoplasia IQ: long-term outcome after cold-knife conismion with clewmargins [J]. Chaletnical, 2001 ; 97 : 428-430
5Sarian LO, Derchain SF, Andrade LA, et al. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia. Gynecol Oncol, 2004,94 : 181-186.
6Numnum TM, Kirby To, Leath CA 3rd, et al. A prospective evaluation of "see and treat" in women with HSIL . Pap smear results : is this an appropriate strategy? J Low Genit Tract Dis, 2005,9:2-6.
7Livasy CA, Maygarden SJ, Rajaratnam CT, et al. Predictors of recurrent dysplasia after a cervical loop electrocautery excision procedure for CIN-3: a study of margin, endocervical gland, and quadrant involvement . Mod Pathol, 1999,12 : 233-238.
8Reich O, Pickel H, Lahousen M, et al. Cervical intraepithelial neoplasia Ⅲ: long-term outcome after cold-knife conization with clear margins. Obstet Gynecol, 2001,97:428-430.
9Kang SB, Roh JW, Kim JW, et al. A comparison of the therapeutic efficacies of large loop excision of transformation zone and hysterectomy for the treatment of cervical intraepithelial neoplasia Ⅲ.Int J Gynecol Cancer, 2001,11:387-391.
10Corona Gutierrez CM, Tinoco A, Navarro T, et al. Therapeutic vaccination with MVAE2 can eliminate precancerous lesions associated with infection by oncogenic human papillomavims. Human Gene Ther, 2004, 15:421-431.
